The promise of choline-PET/CT in the detection of recurrent prostate cancer: What are the limits of our investigation?

European Urology

Volumn 63, Issue 5, 2013, Pages 797-799

  Schiavina, Riccardo ^a   Martorana, Giuseppe ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CHOLINE; FLUORINE 18; FLUORODEOXYGLUCOSE F 18; PROSTATE SPECIFIC ANTIGEN;

ANDROGEN DEPRIVATION THERAPY; BONE MARROW; BONE METASTASIS; BONE RADIOGRAPHY; BONE SCINTISCANNING; CANCER DIAGNOSIS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CAVA VEIN; CHRONIC DISEASE; CLINICAL PRACTICE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; EDITORIAL; FALSE POSITIVE RESULT; FOLLOW UP; HIGH RISK PATIENT; HUMAN; ILIAC ARTERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; PELVIS; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROSTATE CANCER; SPINE; TOMOTHERAPY; TREATMENT REFUSAL; TUMOR MICROENVIRONMENT; VISCERAL METASTASIS; WHOLE BODY MRI;

CHOLINE; HUMANS; KALLIKREINS; LYMPH NODES; MALE; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS;

EID: 84876016478     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.09.001     Document Type: Editorial

References (11)

1. D. Tilki, O. Reich, and A. Graser 18F-fluoroethylcholine PET/CT identifies lymph node metastasis in patients with prostate-specific antigen failure after radical prostatectomy but underestimates its extent Eur Urol 63 2013 792 796
2. A. Briganti, N. Suardi, and P. Capogrosso Lymphatic spread of nodal metastases in high-risk prostate cancer: the ascending pathway from the pelvis to the retroperitoneum Prostate 72 2012 186 192
3. L. Bubendorf, A. Schöpfer, and U. Wagner Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients Hum Pathol 31 2000 578 583
4. C. Fuccio, P. Castellucci, and R. Schiavina Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy Eur J Radiol 81 2012 893 896
5. H. Kjölhede, G. Ahlgren, and H. Almquist Combined (18) F-fluorocholine and (18) F-fluoride positron emission tomography/computed tomography imaging for staging of high-risk prostate cancer BJU Int 110 2012 1501 1506
6. F.E. Lecouvet, J. El Mouedden, and L. Collette Can whole-body magnetic resonance imaging with diffusion-weighted imaging replace Tc 99m bone scanning and computed tomography for single-step detection of metastases in patients with high-risk prostate cancer? Eur Urol 62 2012 68 75
7. P. Castellucci, C. Fuccio, and D. Rubello Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? Eur J Nucl Med Mol Imaging 38 2011 55 63
8. P. Rigatti, N. Suardi, and A. Briganti Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography Eur Urol 60 2011 935 943
9. A. Winter, J. Uphoff, R.P. Henke, and F. Wawroschek Complete PSA remission without adjuvant therapy after secondary lymph node surgery in selected patients with biochemical relapse after radical prostatectomy and pelvic lymph node dissection Adv Urol 2012 2012 609612
10. G. Martorana, R. Schiavina, and A. Franceschelli Should we perform imaging-guided lymph node dissection in patients with lymphatic recurrence of prostate cancer after radical prostatectomy? Eur Urol 55 2009 1302 1304
11. M.C. Schumacher, F.C. Burkhard, G.N. Thalmann, A. Fleischmann, and U.E. Studer Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy Eur Urol 54 2008 344 352